Shingo Kanda

No ORCID on file · 3 papers in corpus · active 2019-2020

Study types

  • article 3

Condition tags

  • dysmenorrhea 3
  • endometriosis 1
  • adenomyosis 1
article 2020
A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea
·doi:10.1016/j.fertnstert.2019.11.010
article 2020
Long‐term use of dienogest for the treatment of primary and secondary dysmenorrhea
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14209

AIM: To investigate the safety and efficacy of dienogest (DNG), a progestational 19-norsteroid, administered for 52 weeks in patients with primary and secondary dysmenorrhea. METHODS: A total of 147 patients with dysmenorrhea received 1 mg …

article 2019
Evaluation of the efficacy, safety, and clinically recommended dose of dienogest in the treatment of primary dysmenorrhea: a randomized, double-blind, multicenter, placebo-controlled study
·doi:10.1016/j.fertnstert.2019.09.014